BioRestorative Therapies, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BRTX for the last quarter is 19.30 k USD, and it's 37.13% lower compared to the previous quarter. The net income of Q4 23 is -2.83 M USD.